We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FOUR:NYSEShift4 Payments, Inc. Analysis

Data as of 2026-06-11 - not real-time

$39.45

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Shift4 Payments is trading well below its 20‑day and 50‑day moving averages, with a bearish MACD and an RSI hovering in neutral territory, indicating short‑term price pressure. Volatility is elevated and beta exceeds the market, reflecting a high‑risk price environment, while the stock benefits from a strong revenue expansion of over 30% year‑over‑year and a forward P/E that suggests earnings are set to accelerate sharply. Recent partnership announcements with high‑visibility sports venues underscore the company’s growth narrative, and the discounted DCF model points to a substantial upside potential relative to the current market price.
Analyst sentiment remains positive, with a consensus “Buy” and target prices well above today’s level, but the balance sheet is heavily leveraged, debt‑to‑equity is extreme, and the firm carries no dividend, which amplifies financial risk. Investors should weigh the compelling growth and valuation upside against the technical weakness, high volatility, and leverage concerns when forming a view.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical indicators and high volatility
  • Increasing trading volume supporting liquidity
  • Revenue momentum but earnings pressure

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong YoY revenue growth and expanding partnership pipeline
  • Forward earnings compression and low forward P/E
  • Valuation upside indicated by DCF model

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strategic positioning in the payments infrastructure market
  • Sustained growth trajectory and improving profitability metrics
  • Potential for balance‑sheet deleveraging as cash flow improves

Key Metrics & Analysis

Financial Health

Revenue Growth32.20%
Profit Margin2.63%
P/E Ratio45.3
ROE9.94%
ROA3.67%
Debt/Equity257.42
P/B Ratio4.8
Op. Cash Flow$672.0M
Free Cash Flow$488.4M
Industry P/E36.5

Technical Analysis

TrendBearish
RSI44.4
Support$34.56
Resistance$45.70
MA 20$41.38
MA 50$43.39
MA 200$61.02
MACDBearish
VolumeIncreasing
Fear & Greed Index86.61

Valuation

Fair Value$134.35
Target Price$60.62
Upside/Downside53.66%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.62
Volatility69.18%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.